[EN] ANTIDIABETIC COMPOUNDS AND COMPOSITIONS<br/>[FR] COMPOSES ANTIDIABÉTIQUES ET COMPOSITIONS
申请人:[en]REZUBIO PHARMACEUTICALS CO., LTD
公开号:WO2023134712A1
公开(公告)日:2023-07-20
Provided herein are novel compounds (e.g., Formula I, II, II-B, III, or III-B), pharmaceutical compositions, and methods of using related to GPR40. The compounds herein are typically GPR40 agonists, which can be used for treating a variety of disorders, conditions or diseases such as Type 2 diabetes.